Chinese Aliler and Noro virus infection enters the high incidence season, and Anti -virus drug Oszhewe was fired again.Many pharmaceutical companies said that Osdhew's production capacity is no problem and will be expelled according to demand in the future.
According to the surging news report, the latest approved company Shuanglu Pharmaceutical Olympic Weili Capsule was approved by the State Drug Administration on December 20 last year, with two specifications: 30mg and 75mg.The company said that it will be produced according to the number of orders, and the production will be carried out if the order increases in the future.The company did not disclose specific data on the volume and output of orders.
Another pharmaceutical company Yipinhong Company said that the company mainly implements the principle of "selling production", that is, formulating production plans according to the sales plan and inventory conditions, and adjusting the market demand in a timely manner to realize multiple variety of high -efficiency production production in accordance with market demand to achieve high -efficiency production of multiple varieties of efficient production., To improve the level of balance production.As the company's Nansha Lianrui Intelligent Production Base is officially put into use, the company's production capacity is currently able to fully meet the company's business development needs.
Osdowewei is a specific inhibitor that acts on neurophanase, which can inhibit the further increase in the number of influenza viruses, thereby suppressing influenza viruses in the body to reduce pathogenicity. The main use is mainly used.Treatment and prevention of influenza B and B.
